Keyphrases
Monogenic
100%
Quality of Life
100%
Subthalamic nucleus
100%
Fronto
100%
Transcranial Magnetic Stimulation
100%
ATP13A2
100%
Early Parkinson's Disease
100%
Motor Pathways
100%
Limbic Brain
100%
Subthalamic
100%
Olfactory Dysfunction
100%
Action Control
100%
Cortical Changes
100%
Excitability
100%
Mutation Carriers
100%
Inferior Frontal Gyrus
83%
Compound Heterozygous mutation
75%
Interhemispheric Inhibition
75%
Gray Matter Volume
71%
Supplementary Motor Area
66%
Ipsilateral Silent Period
50%
Heterozygous mutation
50%
Interhemispheric
50%
ATP13A2 Gene
50%
Intracortical Inhibition
50%
Manifesting Carriers
42%
Superior Frontal
42%
Piriform Cortex
42%
Area Function
33%
Response Tendencies
33%
Non-invasive Brain Stimulation
33%
Olfactory Deprivation
28%
PD-related Genes
28%
Medial Orbitofrontal Cortex (mOFC)
28%
Early Onset
28%
Healthy Controls
28%
Regional Variation
28%
Late-onset
28%
Parkinson
28%
Cortical Volume
28%
Motor Interactions
25%
Chilean
25%
Intracortical
25%
Period Measurement
25%
Short-latency Afferent Inhibition
25%
Contralateral Silent Period
25%
Pallidal
25%
Paired-pulse
25%
Striatal
25%
Neurodegeneration
25%
Neuroscience
Subthalamic Nucleus
100%
Transcranial Magnetic Stimulation
100%
Depression
100%
Parkinson's Disease
100%
Agoraphobia
100%
Excitability
100%
Major Depressive Disorder
100%
Social Anxiety Disorder
100%
Gray Matter
100%
Inferior Frontal Gyrus
83%
Supplementary Motor Area
66%
Superior Frontal Sulcus
60%
Piriform Cortex
60%
Anosmia
60%
Neurodegeneration
50%
Motor Evoked Potential
50%
Orbitofrontal Cortex
40%
Electrical Brain Stimulation
33%
Olfactory Memory
20%
Fronto-Limbic System
20%
Voxel-Based Morphometry
20%
Magnetic Resonance Imaging
20%
Middle Frontal Gyrus
20%
Posterior Cingulate
20%
Functional Magnetic Resonance Imaging
16%
Motor Control
16%